We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
86 hedge funds and large institutions have $276M invested in Invesco Pharmaceuticals ETF in 2014 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 38 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
142% more call options, than puts
Call options by funds: $489K | Put options by funds: $202K
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
1% more funds holding
Funds holding: 85 → 86 (+1)
2.61% less ownership
Funds ownership: 26.28% → 23.68% (-2.6%)
9% less capital invested
Capital invested by funds: $303M → $276M (-$27.2M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
39% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 38
Holders
86
Holders Change
+1
Holders Change %
+1.18%
% of All Funds
2.47%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.11%
New
10
Increased
23
Reduced
38
Closed
9
Calls
$489K
Puts
$202K
Net Calls
+$287K
Net Calls Change
+$287K
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$12.1M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.67M |
| 3 |
PFG
Pacific Financial Group
Bellevue,
Washington
|
-$6.8M |
| 4 |
CM
Churchill Management
Los Angeles,
California
|
-$4.94M |
| 5 |
Morgan Stanley
New York
|
-$4.51M |
